SMALL CELL LUNG CARCINOMA SUB TYPE
Small Cell Lung Carcinoma (SCLC)
... of cell size from small to LCC and that cases falling in the middle are difficult to ...dominant cell population is that of SCLC, one should not diagnose NSCLC based on the presence of a few ...
14
Combined small-cell lung carcinoma
... Histogenesis of C-SCLC Combined tumors raise critical questions regarding the pathogenetic mechanism of each component and the asso- ciation between the entities at hand. The exact mechanisms and histogenesis of C-SCLC ...
7
Chemotherapy for Large Cell Neuroendocrine Carcinoma of the Lung: Should It Be Treated with the Same Strategy as Small Cell Lung Carcinoma?
... of lung diseases that will better enable them to understand respiratory ...acute lung injury/ARDS, pulmonary edema, functional evaluation in respiratory disorders, and a variety of other conditions are also ...
11
Cetuximab and biomarkers in non-small-cell lung carcinoma
... Conclusion EGFR protein expression still has the potential to advance to a biomarker that is able to predict favorable outcomes from cetuximab administration in NSCLC. It is rather dis- appointing that with all the ...
11
Current role of surgery in small cell lung carcinoma
... 15%. This study demonstrated the need of PCI which could prevent brain metastasis [11]. In a recent retrospec- tive analysis Bischof et al [25] reported a median survival of 47 months and 1, 3 and 5 year survival rates ...
6
The value of cytological diagnosis of small cell lung carcinoma
... brushing samples contained numerous malignant cells, sufficient for accurate diagnosis. Rarely, ne- crotic masses or the presence of blood caused in- terpretative problems. More often, nuclear sme- aring was visible; ...
8
TCGA Cancer type abbreviation. Cancer. Lung squamous cell carcinoma. Lung adenocarcinoma. Kidney renal cell carcinoma
... percentage of 741 immune phenotypes differentially expressed in immune cell subsets of DICE database. (D) Of the 741 immune phenotypes, we assessed number of phenotypes considered sex-biased transcripts and DICE ...
Clinical potential of necitumumab in non-small cell lung carcinoma
... in lung cancer patients, and especially in those patients receiving chemotherapy, this toxicity apparently characterizes the whole drug class (while it is not shared with EGFR tyrosine kinase inhibitors); however, ...
11
Spotlight on necitumumab in the treatment of non-small-cell lung carcinoma
... with cell lines from tumors, including epidermis, pancreas, and colorectal, that showed overexpression of ...NSCLC cell lines, necitumumab showed rapid degradation as well as internal- ization of the ...
7
Immunohistochemistry in the differentiation of the non small cell lung carcinoma (NSCLC)
... bioptičkom materijalu Kliničkog zavoda za patologiju i sudsku medicinu KBC-a Osijek, utvrditi učestalost osnovnih podtipova raka pluća u istraživanom materijalu, utvrditi učest[r] ...
34
The importance of EGFR mutation testing in squamous cell carcinoma or non-small cell carcinoma favor squamous cell carcinoma diagnosed from small lung biopsies
... mutations. Lung cancer in never smokers has significant gender and geographic variations, occurring more frequently in female and in ...female lung cancer cases are 83% in South Asia, while only 15% in the ...
8
Discriminant Model for Cytologic Distinction of Large Cell Neuroendocrine Carcinoma from Small Cell Carcinoma of the Lung
... tumor cell cohesion, palisading arrangement of tumor cells, mean of cellular areas, and presence of small cells without prominent nucleoli and naked ...tumor cell clusters were frequently observed in ...
7
Favorable Response of Advanced Superior Sulcus Non-Small Cell Lung Carcinoma to Gefitinib for 11 years complicated by Interval Development of Small Cell Carcinoma of the Lung.
... regarding lung cancer ...with lung cancer to monitor their responses to ...histological type or histologic transformation of the original ...the cell that will trigger another series of ...
10
Surgical pathology of early stage non small cell lung carcinoma
... 1 lung ADCs in order to determine diagnostic accuracy and interobserver variability in histologic subtyping of lung ADCs at the time of frozen section ...
8
Diagnostic Value of KRAS Mutation in Non-small Cell Lung Carcinoma
... wild type DNA sequence and suppressed the wild type amplification while enhancing possible mutant sequences that were competitively binding with the DNA ...
15
Non-small-cell lung carcinoma: role of the Notch signaling pathway
... critical cell fate decisions both in compart- ments that are undergoing differentiation and in pluripotent progenitor ...non-small-cell lung carcinoma ...
11
Docetaxel in the treatment of non-small cell lung carcinoma: an update and analysis
... Tel +1 650 723 9094 Fax +1 650 724 3697 Email [email protected] Abstract: Docetaxel, a semisynthetic taxane, was the first agent to show efficacy in the second-line treatment of non-small cell ...
14
HER3 expression and MEK activation in non-small-cell lung carcinoma
... Non-small-cell lung carcinoma Lung cancer is the leading cause of cancer mortality ...non-small-cell lung carcinoma (NSCLC), of 33 and 6%, respectively [1] ...
12
Surgical Treatment of Stage I Non-small Cell Lung Carcinoma
... too small. 41) Small randomized controlled trial and descriptive studies have shown that the perioperative safety of patients undergoing VATS is as good or super- ior to that those undergoing standard ...
7
Pulmonary atelectasis and survival in advanced non-small cell lung carcinoma
... with lung can- ...pulmonary carcinoma, atelecta- sis is usually developed due to endobronchial obstruc- tion but less frequently due to compression of tumor or pleural ...of lung and prostate cancer ...
5